Meag Munich Ergo’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,160
Closed -$88.5K 185
2023
Q4
$88.5K Hold
1,160
﹤0.01% 165
2023
Q3
$80.4K Hold
1,160
﹤0.01% 170
2023
Q2
$109K Buy
+1,160
New +$101K ﹤0.01% 163
2023
Q1
Sell
-1,004
Closed -$74.9K 202
2022
Q4
$74.9K Hold
1,004
﹤0.01% 207
2022
Q3
$83K Sell
1,004
-3,966
-80% -$382K 0.01% 203
2022
Q2
$473K Buy
4,970
+1,389
+39% +$144K 0.03% 177
2022
Q1
$427K Buy
+3,581
New +$402K 0.03% 175
2021
Q3
Sell
-17,242
Closed -$1.79M 255
2021
Q2
$1.79M Sell
17,242
-11,897
-41% -$1.12M 0.17% 134
2021
Q1
$2.44M Buy
29,139
+17,838
+158% +$1.51M 0.24% 103
2020
Q4
$1.01M Hold
11,301
0.23% 119
2020
Q3
$902K Sell
11,301
-3,786
-25% -$295K 0.17% 135
2020
Q2
$1.04M Sell
15,087
-10,830
-42% -$770K 0.2% 117
2020
Q1
$1.63M Sell
25,917
-11,934
-32% -$861K 0.39% 74
2019
Q4
$2.93M Sell
37,851
-19,341
-34% -$1.51M 0.31% 79
2019
Q3
$4.13M Buy
57,192
+18,756
+49% +$1.32M 0.21% 110
2019
Q2
$2.38M Buy
38,436
+4,539
+13% +$274K 0.19% 120
2019
Q1
$2.13M Buy
33,897
+22,497
+197% +$1.28M 0.18% 134
2018
Q4
$572K Sell
11,400
-58,203
-84% -$2.94M 0.07% 276
2018
Q3
$3.97M Buy
69,603
+21,399
+44% +$1.05M 0.24% 127
2018
Q2
$2.38M Sell
48,204
-63,918
-57% -$2.98M 0.15% 189
2018
Q1
$5.09M Buy
112,122
+81,783
+270% +$3.55M 0.21% 153
2017
Q4
$1.17M Sell
30,339
-139,461
-82% -$5.12M 0.04% 340
2017
Q3
$6.18M Sell
169,800
-20,253
-11% -$772K 0.25% 127
2017
Q2
$7.41M Buy
+190,053
New +$6.94M 0.33% 106
2016
Q4
Sell
-323,988
Closed -$12.9M 292
2016
Q3
$12.9M Buy
+323,988
New +$12.2M 0.64% 47
2016
Q2
Sell
-411,360
Closed -$12.1M 191
2016
Q1
$12.1M Buy
+411,360
New +$11.4M 0.63% 52
2015
Q4
Sell
-592,506
Closed -$13.8M 255
2015
Q3
$13.8M Buy
592,506
+394,350
+199% +$9.52M 0.74% 40
2015
Q2
$4.71M Buy
+198,156
New +$4.47M 0.24% 112

Other funds holding EW